Jose Carmona's most recent trade in Adc Therapeutics SA was a trade of 240,000 Common Shares done at an average price of $1.6 . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adc Therapeutics SA | Jose Carmona | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 13 Feb 2025 | 240,000 | 541,892 | - | 1.6 | 386,400 | Common Shares |
| Adc Therapeutics SA | Jose Carmona | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Dec 2024 | 48,108 | 301,892 | - | 3.1 | 150,578 | Common Shares |